HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
Clinical trial NCT03921294 · TERMINATED
Trial details
- NCT number
- NCT03921294
- Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2022-03-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.